Market closedNon-fractional
Fulgent Genetics/FLGT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Fulgent Genetics
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
Ticker
FLGT
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Providers and Services
Headquarters
El Monte, United States
Employees
1,184
Website
www.fulgentgenetics.com
Fulgent Genetics Metrics
BasicAdvanced
$688M
Market cap
-
P/E ratio
-$5.56
EPS
1.42
Beta
-
Dividend rate
Price and volume
Market cap
$688M
Beta
1.42
Financial strength
Current ratio
5.089
Quick ratio
4.807
Long term debt to equity
0.86
Total debt to equity
1.204
Interest coverage (TTM)
-1,882.95%
Management effectiveness
Return on assets (TTM)
-3.34%
Return on equity (TTM)
-14.46%
Valuation
Price to revenue (TTM)
2.386
Price to book
0.61
Price to tangible book (TTM)
0.61
Price to free cash flow (TTM)
38.228
Growth
Revenue change (TTM)
-21.20%
Earnings per share change (TTM)
539.76%
3-year revenue growth (CAGR)
-28.09%
3-year earnings per share growth (CAGR)
-29.42%
What the Analysts think about Fulgent Genetics
Analyst Ratings
Majority rating from 3 analysts.
Fulgent Genetics Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$64M
-8.65%
Net income
-$13M
-89.54%
Profit margin
-20.80%
-88.55%
Fulgent Genetics Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.08
-$0.39
$0.28
-$0.01
-
Expected
-$0.33
-$0.33
-$0.29
-$0.32
-$0.30
Surprise
-75.61%
18.18%
-197.67%
-96.88%
-
Fulgent Genetics News
AllArticlesVideos
Press release Biocartis NV: Biocartis Welcomes Gina Wallar, PhD as Chief Business Officer and Judith Vacchino, PhD as VP Global Marketing
GlobeNewsWire·2 months ago
Fulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2024 Annual Meeting
Business Wire·2 months ago
Fulgent Reports First Quarter 2024 Financial Results
Business Wire·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Fulgent Genetics stock?
Fulgent Genetics (FLGT) has a market cap of $688M as of July 27, 2024.
What is the P/E ratio for Fulgent Genetics stock?
The price to earnings (P/E) ratio for Fulgent Genetics (FLGT) stock is 0 as of July 27, 2024.
Does Fulgent Genetics stock pay dividends?
No, Fulgent Genetics (FLGT) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Fulgent Genetics dividend payment date?
Fulgent Genetics (FLGT) stock does not pay dividends to its shareholders.
What is the beta indicator for Fulgent Genetics?
Fulgent Genetics (FLGT) has a beta rating of 1.42. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Fulgent Genetics stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.